MedPath

Effects of Sugar-free Products With Added Sweeteners on Glycemic Responses

Not Applicable
Completed
Conditions
Appetitive Behavior
Potential Abnormality of Glucose Tolerance
Registration Number
NCT04857554
Lead Sponsor
Agricultural University of Athens
Brief Summary

This study investigated the effects of three commonly used sugar-free snacks with added sweeteners on glycemic responses

Detailed Description

This study aimed at 1. to determine the glycemic index and glycemic load of three sugar-free products with added sweeteners: apricot jam, cranberry cereal bar, and cocoa drink, and 2. to investigate the effects of these products on the postprandial glycemic response in healthy subjects

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • healthy
  • non-smoking
  • non-diabetic men and women
  • body mass index (BMI) between 18 and 29.9 kg/m2
Exclusion Criteria
  • severe chronic disease (e.g. coronary heart disease, diabetes mellitus,kidney or liver conditions, endocrine conditions)
  • gastrointestinal disorders
  • pregnancy
  • lactation
  • competitive sports
  • alcohol
  • drug dependency

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Capillary blood glucose responses2 hours

Clinically useful change in blood glucose, defined as the restoration of glucose within normal limits during the 2hr glucose tolerance test

Secondary Outcome Measures
NameTimeMethod
Subjective appetite ratings2 hours

Useful change in subjective appetite using visual analogue scales with a score 0 to 10 (given in the form of booklet,one scale per page) at baseline, 15, 30, 45, 60, 90 and 120 min. The minimum or maximum score will be evaluated if it is better or worse depending on the appetite variable e.g hunger, satiety, desire to eat etc.

Trial Locations

Locations (1)

Agricultural University of Athens

🇬🇷

Athens, Attica, Greece

Agricultural University of Athens
🇬🇷Athens, Attica, Greece

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.